nodes	percent_of_prediction	percent_of_DWPC	metapath
Lidocaine—ABCB1—peripheral nervous system neoplasm	0.203	1	CbGaD
Lidocaine—CYP2C18—Tretinoin—peripheral nervous system neoplasm	0.0918	0.165	CbGbCtD
Lidocaine—CYP2A6—Tretinoin—peripheral nervous system neoplasm	0.0446	0.0804	CbGbCtD
Lidocaine—SLC22A5—Dactinomycin—peripheral nervous system neoplasm	0.0437	0.0788	CbGbCtD
Lidocaine—CYP3A7—Tretinoin—peripheral nervous system neoplasm	0.0305	0.055	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Tretinoin—peripheral nervous system neoplasm	0.0305	0.055	CbGbCtD
Lidocaine—CYP2B6—Tretinoin—peripheral nervous system neoplasm	0.029	0.0523	CbGbCtD
Lidocaine—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0229	0.0412	CbGbCtD
Lidocaine—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.022	0.0396	CbGbCtD
Lidocaine—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0183	0.033	CbGbCtD
Lidocaine—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.016	0.0289	CbGbCtD
Lidocaine—ABCB1—Topotecan—peripheral nervous system neoplasm	0.016	0.0289	CbGbCtD
Lidocaine—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0153	0.0276	CbGbCtD
Lidocaine—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0146	0.0264	CbGbCtD
Lidocaine—CYP3A7—Vincristine—peripheral nervous system neoplasm	0.014	0.0252	CbGbCtD
Lidocaine—CYP3A7-CYP3A51P—Vincristine—peripheral nervous system neoplasm	0.014	0.0252	CbGbCtD
Lidocaine—CYP2B6—Cisplatin—peripheral nervous system neoplasm	0.0124	0.0224	CbGbCtD
Lidocaine—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0111	0.02	CbGbCtD
Lidocaine—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0105	0.0189	CbGbCtD
Lidocaine—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.00963	0.0173	CbGbCtD
Lidocaine—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0096	0.0173	CbGbCtD
Lidocaine—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.00925	0.0167	CbGbCtD
Lidocaine—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.00892	0.0161	CbGbCtD
Lidocaine—CYP2B6—Doxorubicin—peripheral nervous system neoplasm	0.00833	0.015	CbGbCtD
Lidocaine—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.00716	0.0129	CbGbCtD
Lidocaine—ABCB1—Vincristine—peripheral nervous system neoplasm	0.00684	0.0123	CbGbCtD
Lidocaine—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.00657	0.0118	CbGbCtD
Lidocaine—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.00638	0.0115	CbGbCtD
Lidocaine—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00626	0.0113	CbGbCtD
Lidocaine—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00427	0.0077	CbGbCtD
Lidocaine—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0041	0.00738	CbGbCtD
Lidocaine—CYP2D6—Doxorubicin—peripheral nervous system neoplasm	0.00403	0.00725	CbGbCtD
Lidocaine—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00375	0.00676	CbGbCtD
Lidocaine—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00256	0.00461	CbGbCtD
Lidocaine—Chloroprocaine—BCHE—peripheral nervous system neoplasm	0.00115	0.669	CrCbGaD
Lidocaine—SCN3A—spinal nerve—peripheral nervous system neoplasm	0.000833	0.463	CbGeAlD
Lidocaine—Procainamide—BCHE—peripheral nervous system neoplasm	0.00057	0.331	CrCbGaD
Lidocaine—SCN10A—nerve—peripheral nervous system neoplasm	0.000176	0.0977	CbGeAlD
Lidocaine—SCN10A—ganglion—peripheral nervous system neoplasm	0.000174	0.0965	CbGeAlD
Lidocaine—Urticaria—Topotecan—peripheral nervous system neoplasm	0.000153	0.000816	CcSEcCtD
Lidocaine—Urticaria—Isotretinoin—peripheral nervous system neoplasm	0.000152	0.000809	CcSEcCtD
Lidocaine—Urticaria—Tretinoin—peripheral nervous system neoplasm	0.000152	0.000809	CcSEcCtD
Lidocaine—Erythema—Cisplatin—peripheral nervous system neoplasm	0.000151	0.000806	CcSEcCtD
Lidocaine—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000806	CcSEcCtD
Lidocaine—Anxiety—Alitretinoin—peripheral nervous system neoplasm	0.000151	0.000803	CcSEcCtD
Lidocaine—Coma—Doxorubicin—peripheral nervous system neoplasm	0.00015	0.000801	CcSEcCtD
Lidocaine—Urticaria—Melphalan—peripheral nervous system neoplasm	0.00015	0.000799	CcSEcCtD
Lidocaine—Eye disorder—Etoposide—peripheral nervous system neoplasm	0.000149	0.000793	CcSEcCtD
Lidocaine—Convulsion—Vincristine—peripheral nervous system neoplasm	0.000148	0.00079	CcSEcCtD
Lidocaine—Cardiac disorder—Etoposide—peripheral nervous system neoplasm	0.000148	0.000787	CcSEcCtD
Lidocaine—Flushing—Etoposide—peripheral nervous system neoplasm	0.000148	0.000787	CcSEcCtD
Lidocaine—Hypertension—Vincristine—peripheral nervous system neoplasm	0.000148	0.000787	CcSEcCtD
Lidocaine—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000146	0.000779	CcSEcCtD
Lidocaine—Anaphylactic shock—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.000772	CcSEcCtD
Lidocaine—Oedema—Alitretinoin—peripheral nervous system neoplasm	0.000145	0.000772	CcSEcCtD
Lidocaine—Angiopathy—Etoposide—peripheral nervous system neoplasm	0.000145	0.00077	CcSEcCtD
Lidocaine—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000144	0.000766	CcSEcCtD
Lidocaine—Chills—Etoposide—peripheral nervous system neoplasm	0.000143	0.000761	CcSEcCtD
Lidocaine—Vision blurred—Cisplatin—peripheral nervous system neoplasm	0.000143	0.00076	CcSEcCtD
Lidocaine—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000143	0.00076	CcSEcCtD
Lidocaine—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000142	0.000757	CcSEcCtD
Lidocaine—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000142	0.000757	CcSEcCtD
Lidocaine—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000142	0.000755	CcSEcCtD
Lidocaine—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000141	0.000751	CcSEcCtD
Lidocaine—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000141	0.000751	CcSEcCtD
Lidocaine—Hyperhidrosis—Alitretinoin—peripheral nervous system neoplasm	0.00014	0.000747	CcSEcCtD
Lidocaine—Anaphylactic shock—Vincristine—peripheral nervous system neoplasm	0.00014	0.000744	CcSEcCtD
Lidocaine—Oedema—Vincristine—peripheral nervous system neoplasm	0.00014	0.000744	CcSEcCtD
Lidocaine—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000139	0.000741	CcSEcCtD
Lidocaine—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000138	0.000737	CcSEcCtD
Lidocaine—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000137	0.000731	CcSEcCtD
Lidocaine—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000137	0.000731	CcSEcCtD
Lidocaine—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000137	0.00073	CcSEcCtD
Lidocaine—Dysgeusia—Etoposide—peripheral nervous system neoplasm	0.000136	0.000723	CcSEcCtD
Lidocaine—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000136	0.000722	CcSEcCtD
Lidocaine—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000136	0.000722	CcSEcCtD
Lidocaine—Hyperhidrosis—Vincristine—peripheral nervous system neoplasm	0.000135	0.000719	CcSEcCtD
Lidocaine—Dermatitis bullous—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000719	CcSEcCtD
Lidocaine—Back pain—Etoposide—peripheral nervous system neoplasm	0.000134	0.000714	CcSEcCtD
Lidocaine—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000134	0.000712	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Epirubicin—peripheral nervous system neoplasm	0.000133	0.00071	CcSEcCtD
Lidocaine—Convulsion—Cisplatin—peripheral nervous system neoplasm	0.000131	0.000699	CcSEcCtD
Lidocaine—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000131	0.000695	CcSEcCtD
Lidocaine—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.00013	0.000693	CcSEcCtD
Lidocaine—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.000688	CcSEcCtD
Lidocaine—Osteoarthritis—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000687	CcSEcCtD
Lidocaine—Diplopia—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000687	CcSEcCtD
Lidocaine—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000129	0.000687	CcSEcCtD
Lidocaine—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000129	0.000686	CcSEcCtD
Lidocaine—Anxiety—Cisplatin—peripheral nervous system neoplasm	0.000129	0.000684	CcSEcCtD
Lidocaine—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000128	0.000679	CcSEcCtD
Lidocaine—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000127	0.000674	CcSEcCtD
Lidocaine—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000127	0.000674	CcSEcCtD
Lidocaine—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000126	0.000668	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000125	0.000667	CcSEcCtD
Lidocaine—Dermatitis bullous—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000666	CcSEcCtD
Lidocaine—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000124	0.00066	CcSEcCtD
Lidocaine—Oedema—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000658	CcSEcCtD
Lidocaine—Anaphylactic shock—Cisplatin—peripheral nervous system neoplasm	0.000124	0.000658	CcSEcCtD
Lidocaine—Anaphylactoid reaction—Doxorubicin—peripheral nervous system neoplasm	0.000124	0.000657	CcSEcCtD
Lidocaine—Cardiac arrest—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000654	CcSEcCtD
Lidocaine—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000123	0.000653	CcSEcCtD
Lidocaine—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000122	0.000649	CcSEcCtD
Lidocaine—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000122	0.000648	CcSEcCtD
Lidocaine—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000122	0.000648	CcSEcCtD
Lidocaine—Rash—Topotecan—peripheral nervous system neoplasm	0.000122	0.000648	CcSEcCtD
Lidocaine—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000122	0.000647	CcSEcCtD
Lidocaine—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000645	CcSEcCtD
Lidocaine—Headache—Topotecan—peripheral nervous system neoplasm	0.000121	0.000643	CcSEcCtD
Lidocaine—Rash—Tretinoin—peripheral nervous system neoplasm	0.000121	0.000642	CcSEcCtD
Lidocaine—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000121	0.000642	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000121	0.000642	CcSEcCtD
Lidocaine—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000121	0.000642	CcSEcCtD
Lidocaine—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000121	0.000642	CcSEcCtD
Lidocaine—Convulsion—Etoposide—peripheral nervous system neoplasm	0.00012	0.00064	CcSEcCtD
Lidocaine—Vomiting—Melphalan—peripheral nervous system neoplasm	0.00012	0.000639	CcSEcCtD
Lidocaine—Headache—Tretinoin—peripheral nervous system neoplasm	0.00012	0.000638	CcSEcCtD
Lidocaine—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00012	0.000638	CcSEcCtD
Lidocaine—Hypertension—Etoposide—peripheral nervous system neoplasm	0.00012	0.000638	CcSEcCtD
Lidocaine—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.00012	0.000636	CcSEcCtD
Lidocaine—Pain—Vincristine—peripheral nervous system neoplasm	0.00012	0.000636	CcSEcCtD
Lidocaine—Diplopia—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000636	CcSEcCtD
Lidocaine—Osteoarthritis—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000636	CcSEcCtD
Lidocaine—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.00012	0.000636	CcSEcCtD
Lidocaine—Rash—Melphalan—peripheral nervous system neoplasm	0.000119	0.000634	CcSEcCtD
Lidocaine—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000119	0.000634	CcSEcCtD
Lidocaine—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000118	0.000629	CcSEcCtD
Lidocaine—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000116	0.000615	CcSEcCtD
Lidocaine—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000115	0.000614	CcSEcCtD
Lidocaine—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000115	0.000613	CcSEcCtD
Lidocaine—Nausea—Topotecan—peripheral nervous system neoplasm	0.000115	0.00061	CcSEcCtD
Lidocaine—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000114	0.000608	CcSEcCtD
Lidocaine—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000114	0.000605	CcSEcCtD
Lidocaine—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000114	0.000605	CcSEcCtD
Lidocaine—Cardiac arrest—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000605	CcSEcCtD
Lidocaine—Anaphylactic shock—Etoposide—peripheral nervous system neoplasm	0.000113	0.000603	CcSEcCtD
Lidocaine—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000112	0.000598	CcSEcCtD
Lidocaine—Nausea—Melphalan—peripheral nervous system neoplasm	0.000112	0.000597	CcSEcCtD
Lidocaine—SCN9A—trigeminal ganglion—peripheral nervous system neoplasm	0.000112	0.0623	CbGeAlD
Lidocaine—Asthma—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000594	CcSEcCtD
Lidocaine—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000594	CcSEcCtD
Lidocaine—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000111	0.000591	CcSEcCtD
Lidocaine—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00011	0.000587	CcSEcCtD
Lidocaine—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00011	0.000583	CcSEcCtD
Lidocaine—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000107	0.000569	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000107	0.000568	CcSEcCtD
Lidocaine—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000106	0.000563	CcSEcCtD
Lidocaine—Pain—Cisplatin—peripheral nervous system neoplasm	0.000106	0.000563	CcSEcCtD
Lidocaine—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000104	0.000554	CcSEcCtD
Lidocaine—Asthma—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00055	CcSEcCtD
Lidocaine—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.00055	CcSEcCtD
Lidocaine—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000103	0.000548	CcSEcCtD
Lidocaine—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000102	0.000542	CcSEcCtD
Lidocaine—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000102	0.000541	CcSEcCtD
Lidocaine—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000101	0.000537	CcSEcCtD
Lidocaine—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000101	0.000536	CcSEcCtD
Lidocaine—Asthenia—Vincristine—peripheral nervous system neoplasm	0.0001	0.000534	CcSEcCtD
Lidocaine—Drowsiness—Epirubicin—peripheral nervous system neoplasm	9.96e-05	0.00053	CcSEcCtD
Lidocaine—Vomiting—Dactinomycin—peripheral nervous system neoplasm	9.95e-05	0.00053	CcSEcCtD
Lidocaine—Rash—Dactinomycin—peripheral nervous system neoplasm	9.87e-05	0.000525	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	9.78e-05	0.00052	CcSEcCtD
Lidocaine—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	9.76e-05	0.000519	CcSEcCtD
Lidocaine—Stomatitis—Epirubicin—peripheral nervous system neoplasm	9.7e-05	0.000516	CcSEcCtD
Lidocaine—Pain—Etoposide—peripheral nervous system neoplasm	9.69e-05	0.000515	CcSEcCtD
Lidocaine—Dizziness—Alitretinoin—peripheral nervous system neoplasm	9.6e-05	0.000511	CcSEcCtD
Lidocaine—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	9.33e-05	0.000497	CcSEcCtD
Lidocaine—Nausea—Dactinomycin—peripheral nervous system neoplasm	9.3e-05	0.000495	CcSEcCtD
Lidocaine—Dizziness—Vincristine—peripheral nervous system neoplasm	9.25e-05	0.000492	CcSEcCtD
Lidocaine—Vomiting—Alitretinoin—peripheral nervous system neoplasm	9.23e-05	0.000491	CcSEcCtD
Lidocaine—Drowsiness—Doxorubicin—peripheral nervous system neoplasm	9.21e-05	0.00049	CcSEcCtD
Lidocaine—Rash—Alitretinoin—peripheral nervous system neoplasm	9.15e-05	0.000487	CcSEcCtD
Lidocaine—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	9.14e-05	0.000486	CcSEcCtD
Lidocaine—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	9.11e-05	0.000485	CcSEcCtD
Lidocaine—Bradycardia—Epirubicin—peripheral nervous system neoplasm	9.1e-05	0.000484	CcSEcCtD
Lidocaine—Headache—Alitretinoin—peripheral nervous system neoplasm	9.09e-05	0.000484	CcSEcCtD
Lidocaine—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	9.03e-05	0.000481	CcSEcCtD
Lidocaine—Urticaria—Etoposide—peripheral nervous system neoplasm	9e-05	0.000479	CcSEcCtD
Lidocaine—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	8.98e-05	0.000478	CcSEcCtD
Lidocaine—Stomatitis—Doxorubicin—peripheral nervous system neoplasm	8.98e-05	0.000478	CcSEcCtD
Lidocaine—Rhinitis—Epirubicin—peripheral nervous system neoplasm	8.96e-05	0.000477	CcSEcCtD
Lidocaine—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	8.94e-05	0.000476	CcSEcCtD
Lidocaine—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	8.89e-05	0.000473	CcSEcCtD
Lidocaine—Vomiting—Vincristine—peripheral nervous system neoplasm	8.89e-05	0.000473	CcSEcCtD
Lidocaine—Asthenia—Cisplatin—peripheral nervous system neoplasm	8.87e-05	0.000472	CcSEcCtD
Lidocaine—Rash—Vincristine—peripheral nervous system neoplasm	8.82e-05	0.000469	CcSEcCtD
Lidocaine—Dermatitis—Vincristine—peripheral nervous system neoplasm	8.81e-05	0.000469	CcSEcCtD
Lidocaine—Headache—Vincristine—peripheral nervous system neoplasm	8.76e-05	0.000466	CcSEcCtD
Lidocaine—Nausea—Alitretinoin—peripheral nervous system neoplasm	8.62e-05	0.000459	CcSEcCtD
Lidocaine—Visual impairment—Epirubicin—peripheral nervous system neoplasm	8.61e-05	0.000458	CcSEcCtD
Lidocaine—SCN10A—trigeminal ganglion—peripheral nervous system neoplasm	8.54e-05	0.0474	CbGeAlD
Lidocaine—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	8.42e-05	0.000448	CcSEcCtD
Lidocaine—Eye disorder—Epirubicin—peripheral nervous system neoplasm	8.35e-05	0.000444	CcSEcCtD
Lidocaine—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	8.35e-05	0.000444	CcSEcCtD
Lidocaine—Tinnitus—Epirubicin—peripheral nervous system neoplasm	8.33e-05	0.000443	CcSEcCtD
Lidocaine—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	8.31e-05	0.000442	CcSEcCtD
Lidocaine—Nausea—Vincristine—peripheral nervous system neoplasm	8.31e-05	0.000442	CcSEcCtD
Lidocaine—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.000441	CcSEcCtD
Lidocaine—Flushing—Epirubicin—peripheral nervous system neoplasm	8.29e-05	0.000441	CcSEcCtD
Lidocaine—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	8.29e-05	0.000441	CcSEcCtD
Lidocaine—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	8.27e-05	0.00044	CcSEcCtD
Lidocaine—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	8.23e-05	0.000438	CcSEcCtD
Lidocaine—Asthenia—Etoposide—peripheral nervous system neoplasm	8.13e-05	0.000432	CcSEcCtD
Lidocaine—Angiopathy—Epirubicin—peripheral nervous system neoplasm	8.11e-05	0.000431	CcSEcCtD
Lidocaine—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	8.07e-05	0.00043	CcSEcCtD
Lidocaine—Chills—Epirubicin—peripheral nervous system neoplasm	8.02e-05	0.000427	CcSEcCtD
Lidocaine—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	7.97e-05	0.000424	CcSEcCtD
Lidocaine—Vomiting—Cisplatin—peripheral nervous system neoplasm	7.86e-05	0.000418	CcSEcCtD
Lidocaine—SCN2A—brainstem—peripheral nervous system neoplasm	7.84e-05	0.0435	CbGeAlD
Lidocaine—Rash—Cisplatin—peripheral nervous system neoplasm	7.8e-05	0.000415	CcSEcCtD
Lidocaine—Dermatitis—Cisplatin—peripheral nervous system neoplasm	7.79e-05	0.000414	CcSEcCtD
Lidocaine—Erythema—Epirubicin—peripheral nervous system neoplasm	7.78e-05	0.000414	CcSEcCtD
Lidocaine—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	7.73e-05	0.000411	CcSEcCtD
Lidocaine—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	7.71e-05	0.00041	CcSEcCtD
Lidocaine—Flushing—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000408	CcSEcCtD
Lidocaine—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	7.67e-05	0.000408	CcSEcCtD
Lidocaine—Tension—Epirubicin—peripheral nervous system neoplasm	7.63e-05	0.000406	CcSEcCtD
Lidocaine—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	7.62e-05	0.000405	CcSEcCtD
Lidocaine—Nervousness—Epirubicin—peripheral nervous system neoplasm	7.56e-05	0.000402	CcSEcCtD
Lidocaine—Back pain—Epirubicin—peripheral nervous system neoplasm	7.53e-05	0.0004	CcSEcCtD
Lidocaine—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	7.5e-05	0.000399	CcSEcCtD
Lidocaine—Dizziness—Etoposide—peripheral nervous system neoplasm	7.49e-05	0.000399	CcSEcCtD
Lidocaine—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	7.47e-05	0.000397	CcSEcCtD
Lidocaine—Chills—Doxorubicin—peripheral nervous system neoplasm	7.42e-05	0.000395	CcSEcCtD
Lidocaine—Nausea—Cisplatin—peripheral nervous system neoplasm	7.34e-05	0.000391	CcSEcCtD
Lidocaine—Vision blurred—Epirubicin—peripheral nervous system neoplasm	7.33e-05	0.00039	CcSEcCtD
Lidocaine—Vomiting—Etoposide—peripheral nervous system neoplasm	7.2e-05	0.000383	CcSEcCtD
Lidocaine—Erythema—Doxorubicin—peripheral nervous system neoplasm	7.2e-05	0.000383	CcSEcCtD
Lidocaine—Agitation—Epirubicin—peripheral nervous system neoplasm	7.15e-05	0.00038	CcSEcCtD
Lidocaine—Rash—Etoposide—peripheral nervous system neoplasm	7.14e-05	0.00038	CcSEcCtD
Lidocaine—Dermatitis—Etoposide—peripheral nervous system neoplasm	7.14e-05	0.00038	CcSEcCtD
Lidocaine—Headache—Etoposide—peripheral nervous system neoplasm	7.1e-05	0.000378	CcSEcCtD
Lidocaine—Tension—Doxorubicin—peripheral nervous system neoplasm	7.06e-05	0.000376	CcSEcCtD
Lidocaine—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.000375	CcSEcCtD
Lidocaine—Nervousness—Doxorubicin—peripheral nervous system neoplasm	6.99e-05	0.000372	CcSEcCtD
Lidocaine—Back pain—Doxorubicin—peripheral nervous system neoplasm	6.96e-05	0.000371	CcSEcCtD
Lidocaine—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000364	CcSEcCtD
Lidocaine—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	6.78e-05	0.000361	CcSEcCtD
Lidocaine—Convulsion—Epirubicin—peripheral nervous system neoplasm	6.74e-05	0.000359	CcSEcCtD
Lidocaine—Nausea—Etoposide—peripheral nervous system neoplasm	6.73e-05	0.000358	CcSEcCtD
Lidocaine—Hypertension—Epirubicin—peripheral nervous system neoplasm	6.72e-05	0.000357	CcSEcCtD
Lidocaine—Chest pain—Epirubicin—peripheral nervous system neoplasm	6.62e-05	0.000352	CcSEcCtD
Lidocaine—Agitation—Doxorubicin—peripheral nervous system neoplasm	6.62e-05	0.000352	CcSEcCtD
Lidocaine—Anxiety—Epirubicin—peripheral nervous system neoplasm	6.6e-05	0.000351	CcSEcCtD
Lidocaine—Confusional state—Epirubicin—peripheral nervous system neoplasm	6.4e-05	0.000341	CcSEcCtD
Lidocaine—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000338	CcSEcCtD
Lidocaine—Oedema—Epirubicin—peripheral nervous system neoplasm	6.35e-05	0.000338	CcSEcCtD
Lidocaine—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000337	CcSEcCtD
Lidocaine—Shock—Epirubicin—peripheral nervous system neoplasm	6.25e-05	0.000332	CcSEcCtD
Lidocaine—Convulsion—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000332	CcSEcCtD
Lidocaine—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	6.23e-05	0.000331	CcSEcCtD
Lidocaine—Hypertension—Doxorubicin—peripheral nervous system neoplasm	6.21e-05	0.000331	CcSEcCtD
Lidocaine—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000327	CcSEcCtD
Lidocaine—Chest pain—Doxorubicin—peripheral nervous system neoplasm	6.13e-05	0.000326	CcSEcCtD
Lidocaine—Anxiety—Doxorubicin—peripheral nervous system neoplasm	6.11e-05	0.000325	CcSEcCtD
Lidocaine—EGFR—cerebellum—peripheral nervous system neoplasm	5.94e-05	0.033	CbGeAlD
Lidocaine—Hypotension—Epirubicin—peripheral nervous system neoplasm	5.93e-05	0.000316	CcSEcCtD
Lidocaine—Confusional state—Doxorubicin—peripheral nervous system neoplasm	5.92e-05	0.000315	CcSEcCtD
Lidocaine—Oedema—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000313	CcSEcCtD
Lidocaine—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	5.87e-05	0.000313	CcSEcCtD
Lidocaine—Shock—Doxorubicin—peripheral nervous system neoplasm	5.78e-05	0.000308	CcSEcCtD
Lidocaine—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	5.76e-05	0.000307	CcSEcCtD
Lidocaine—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	5.7e-05	0.000303	CcSEcCtD
Lidocaine—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000302	CcSEcCtD
Lidocaine—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	5.66e-05	0.000301	CcSEcCtD
Lidocaine—Somnolence—Epirubicin—peripheral nervous system neoplasm	5.64e-05	0.0003	CcSEcCtD
Lidocaine—Hypotension—Doxorubicin—peripheral nervous system neoplasm	5.49e-05	0.000292	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	5.48e-05	0.000292	CcSEcCtD
Lidocaine—Pain—Epirubicin—peripheral nervous system neoplasm	5.43e-05	0.000289	CcSEcCtD
Lidocaine—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	5.28e-05	0.000281	CcSEcCtD
Lidocaine—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	5.24e-05	0.000279	CcSEcCtD
Lidocaine—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	5.23e-05	0.000278	CcSEcCtD
Lidocaine—Somnolence—Doxorubicin—peripheral nervous system neoplasm	5.22e-05	0.000278	CcSEcCtD
Lidocaine—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	5.07e-05	0.00027	CcSEcCtD
Lidocaine—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.04e-05	0.000268	CcSEcCtD
Lidocaine—Pain—Doxorubicin—peripheral nervous system neoplasm	5.02e-05	0.000267	CcSEcCtD
Lidocaine—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	4.84e-05	0.000258	CcSEcCtD
Lidocaine—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	4.68e-05	0.000249	CcSEcCtD
Lidocaine—Urticaria—Doxorubicin—peripheral nervous system neoplasm	4.67e-05	0.000248	CcSEcCtD
Lidocaine—Asthenia—Epirubicin—peripheral nervous system neoplasm	4.56e-05	0.000242	CcSEcCtD
Lidocaine—SLC22A5—trigeminal ganglion—peripheral nervous system neoplasm	4.51e-05	0.025	CbGeAlD
Lidocaine—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	4.33e-05	0.00023	CcSEcCtD
Lidocaine—SLC22A5—parotid gland—peripheral nervous system neoplasm	4.25e-05	0.0236	CbGeAlD
Lidocaine—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.22e-05	0.000224	CcSEcCtD
Lidocaine—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.2e-05	0.000223	CcSEcCtD
Lidocaine—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.04e-05	0.000215	CcSEcCtD
Lidocaine—Rash—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000213	CcSEcCtD
Lidocaine—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4e-05	0.000213	CcSEcCtD
Lidocaine—Headache—Epirubicin—peripheral nervous system neoplasm	3.98e-05	0.000212	CcSEcCtD
Lidocaine—Dizziness—Doxorubicin—peripheral nervous system neoplasm	3.88e-05	0.000207	CcSEcCtD
Lidocaine—SCN2A—cerebellum—peripheral nervous system neoplasm	3.86e-05	0.0215	CbGeAlD
Lidocaine—Nausea—Epirubicin—peripheral nervous system neoplasm	3.77e-05	0.000201	CcSEcCtD
Lidocaine—Vomiting—Doxorubicin—peripheral nervous system neoplasm	3.74e-05	0.000199	CcSEcCtD
Lidocaine—Rash—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000197	CcSEcCtD
Lidocaine—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	3.7e-05	0.000197	CcSEcCtD
Lidocaine—Headache—Doxorubicin—peripheral nervous system neoplasm	3.68e-05	0.000196	CcSEcCtD
Lidocaine—Nausea—Doxorubicin—peripheral nervous system neoplasm	3.49e-05	0.000186	CcSEcCtD
Lidocaine—SCN3A—cerebellum—peripheral nervous system neoplasm	3.4e-05	0.0189	CbGeAlD
Lidocaine—CYP2A6—cerebellum—peripheral nervous system neoplasm	3.39e-05	0.0188	CbGeAlD
Lidocaine—EGFR—B Cell Activation—NRAS—peripheral nervous system neoplasm	2.92e-05	0.000581	CbGpPWpGaD
Lidocaine—EGFR—Direct p53 effectors—TP53—peripheral nervous system neoplasm	2.91e-05	0.000579	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—COX2—peripheral nervous system neoplasm	2.87e-05	0.000571	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GNS—peripheral nervous system neoplasm	2.85e-05	0.000567	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ENO2—peripheral nervous system neoplasm	2.83e-05	0.000564	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—ERBB2—peripheral nervous system neoplasm	2.82e-05	0.000562	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NTS—peripheral nervous system neoplasm	2.81e-05	0.000559	CbGpPWpGaD
Lidocaine—EGFR—Disease—PPP3R1—peripheral nervous system neoplasm	2.81e-05	0.000558	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—NRAS—peripheral nervous system neoplasm	2.79e-05	0.000556	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—ERBB2—peripheral nervous system neoplasm	2.79e-05	0.000554	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.77e-05	0.000552	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—HRAS—peripheral nervous system neoplasm	2.77e-05	0.000551	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	2.76e-05	0.00055	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—TP53—peripheral nervous system neoplasm	2.74e-05	0.000545	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—NME1—peripheral nervous system neoplasm	2.73e-05	0.000544	CbGpPWpGaD
Lidocaine—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	2.73e-05	0.000544	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	2.7e-05	0.000537	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CD55—peripheral nervous system neoplasm	2.69e-05	0.000536	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.69e-05	0.000536	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NCAM1—peripheral nervous system neoplasm	2.69e-05	0.000534	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—HRAS—peripheral nervous system neoplasm	2.65e-05	0.000527	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—COX2—peripheral nervous system neoplasm	2.63e-05	0.000523	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—HRAS—peripheral nervous system neoplasm	2.61e-05	0.000519	CbGpPWpGaD
Lidocaine—CYP2D6—brainstem—peripheral nervous system neoplasm	2.58e-05	0.0143	CbGeAlD
Lidocaine—EGFR—Signaling by NGF—CASP3—peripheral nervous system neoplasm	2.56e-05	0.00051	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—ERBB2—peripheral nervous system neoplasm	2.56e-05	0.000508	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—TP53—peripheral nervous system neoplasm	2.52e-05	0.0005	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—MET—peripheral nervous system neoplasm	2.5e-05	0.000496	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—HRAS—peripheral nervous system neoplasm	2.49e-05	0.000495	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.49e-05	0.000495	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—HRAS—peripheral nervous system neoplasm	2.48e-05	0.000493	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—HRAS—peripheral nervous system neoplasm	2.48e-05	0.000493	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—HRAS—peripheral nervous system neoplasm	2.46e-05	0.00049	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—HRAS—peripheral nervous system neoplasm	2.45e-05	0.000488	CbGpPWpGaD
Lidocaine—EGFR—Signaling by SCF-KIT—AKT1—peripheral nervous system neoplasm	2.44e-05	0.000486	CbGpPWpGaD
Lidocaine—EGFR—Disease—ENO2—peripheral nervous system neoplasm	2.43e-05	0.000484	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—peripheral nervous system neoplasm	2.42e-05	0.000481	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—BCHE—peripheral nervous system neoplasm	2.4e-05	0.000477	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.38e-05	0.000474	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.35e-05	0.000467	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling of activated FGFR—AKT1—peripheral nervous system neoplasm	2.34e-05	0.000465	CbGpPWpGaD
Lidocaine—EGFR—Integrated Breast Cancer Pathway—AKT1—peripheral nervous system neoplasm	2.31e-05	0.00046	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—PTPN11—peripheral nervous system neoplasm	2.31e-05	0.000459	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—HRAS—peripheral nervous system neoplasm	2.31e-05	0.000459	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—HRAS—peripheral nervous system neoplasm	2.31e-05	0.000459	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—HRAS—peripheral nervous system neoplasm	2.31e-05	0.000459	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB4—AKT1—peripheral nervous system neoplasm	2.3e-05	0.000458	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—GNS—peripheral nervous system neoplasm	2.3e-05	0.000458	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.29e-05	0.000455	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.29e-05	0.000455	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—HRAS—peripheral nervous system neoplasm	2.29e-05	0.000455	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.29e-05	0.000455	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	2.27e-05	0.000452	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—HRAS—peripheral nervous system neoplasm	2.27e-05	0.000451	CbGpPWpGaD
Lidocaine—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	2.26e-05	0.00045	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—HRAS—peripheral nervous system neoplasm	2.26e-05	0.000449	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—TH—peripheral nervous system neoplasm	2.25e-05	0.000448	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	2.25e-05	0.000447	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	2.24e-05	0.000445	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.21e-05	0.00044	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—NME1—peripheral nervous system neoplasm	2.21e-05	0.000439	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—HRAS—peripheral nervous system neoplasm	2.21e-05	0.000439	CbGpPWpGaD
Lidocaine—EGFR—Downstream signal transduction—AKT1—peripheral nervous system neoplasm	2.2e-05	0.000437	CbGpPWpGaD
Lidocaine—SCN9A—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.2e-05	0.000437	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.19e-05	0.000436	CbGpPWpGaD
Lidocaine—EGFR—EGF/EGFR Signaling Pathway—AKT1—peripheral nervous system neoplasm	2.19e-05	0.000435	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR—AKT1—peripheral nervous system neoplasm	2.19e-05	0.000435	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—HRAS—peripheral nervous system neoplasm	2.18e-05	0.000434	CbGpPWpGaD
Lidocaine—EGFR—Signaling by ERBB2—AKT1—peripheral nervous system neoplasm	2.18e-05	0.000433	CbGpPWpGaD
Lidocaine—SCN5A—Axon guidance—HRAS—peripheral nervous system neoplasm	2.17e-05	0.000432	CbGpPWpGaD
Lidocaine—EGFR—DAP12 signaling—AKT1—peripheral nervous system neoplasm	2.17e-05	0.000431	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	2.16e-05	0.000429	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—NRAS—peripheral nervous system neoplasm	2.15e-05	0.000427	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.14e-05	0.000426	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	2.14e-05	0.000425	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—HRAS—peripheral nervous system neoplasm	2.14e-05	0.000425	CbGpPWpGaD
Lidocaine—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—peripheral nervous system neoplasm	2.13e-05	0.000425	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—VIP—peripheral nervous system neoplasm	2.13e-05	0.000424	CbGpPWpGaD
Lidocaine—EGFR—MAPK Signaling Pathway—AKT1—peripheral nervous system neoplasm	2.12e-05	0.000423	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—COX2—peripheral nervous system neoplasm	2.12e-05	0.000422	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—NRAS—peripheral nervous system neoplasm	2.12e-05	0.000422	CbGpPWpGaD
Lidocaine—EGFR—Immune System—IFNB1—peripheral nervous system neoplasm	2.11e-05	0.000419	CbGpPWpGaD
Lidocaine—SCN3A—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.1e-05	0.000418	CbGpPWpGaD
Lidocaine—ABCB1—trigeminal ganglion—peripheral nervous system neoplasm	2.09e-05	0.0116	CbGeAlD
Lidocaine—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	2.08e-05	0.000413	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—HRAS—peripheral nervous system neoplasm	2.04e-05	0.000407	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—PTPN11—peripheral nervous system neoplasm	2.04e-05	0.000405	CbGpPWpGaD
Lidocaine—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—peripheral nervous system neoplasm	2.04e-05	0.000405	CbGpPWpGaD
Lidocaine—EGFR—DAP12 interactions—AKT1—peripheral nervous system neoplasm	2.04e-05	0.000405	CbGpPWpGaD
Lidocaine—EGFR—Signaling by FGFR in disease—AKT1—peripheral nervous system neoplasm	2.04e-05	0.000405	CbGpPWpGaD
Lidocaine—SCN2A—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.02e-05	0.000402	CbGpPWpGaD
Lidocaine—SCN4A—Developmental Biology—AKT1—peripheral nervous system neoplasm	2.02e-05	0.000402	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR—AKT1—peripheral nervous system neoplasm	2.02e-05	0.000402	CbGpPWpGaD
Lidocaine—EGFR—Signaling by EGFR in Cancer—AKT1—peripheral nervous system neoplasm	2e-05	0.000398	CbGpPWpGaD
Lidocaine—EGFR—Signaling by PDGF—AKT1—peripheral nervous system neoplasm	1.99e-05	0.000396	CbGpPWpGaD
Lidocaine—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	1.98e-05	0.000393	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.97e-05	0.000392	CbGpPWpGaD
Lidocaine—SLC22A5—cerebellum—peripheral nervous system neoplasm	1.97e-05	0.0109	CbGeAlD
Lidocaine—EGFR—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	1.97e-05	0.000391	CbGpPWpGaD
Lidocaine—EGFR—Disease—SLC2A1—peripheral nervous system neoplasm	1.96e-05	0.00039	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—PTPN11—peripheral nervous system neoplasm	1.96e-05	0.000389	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.95e-05	0.000387	CbGpPWpGaD
Lidocaine—SCN10A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.95e-05	0.000387	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—NRAS—peripheral nervous system neoplasm	1.94e-05	0.000387	CbGpPWpGaD
Lidocaine—EGFR—Focal Adhesion—AKT1—peripheral nervous system neoplasm	1.93e-05	0.000383	CbGpPWpGaD
Lidocaine—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	1.92e-05	0.000381	CbGpPWpGaD
Lidocaine—EGFR—B Cell Activation—AKT1—peripheral nervous system neoplasm	1.89e-05	0.000375	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ENO2—peripheral nervous system neoplasm	1.88e-05	0.000375	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.87e-05	0.000373	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	1.87e-05	0.000372	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.87e-05	0.000371	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—GNAS—peripheral nervous system neoplasm	1.84e-05	0.000366	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—ERBB2—peripheral nervous system neoplasm	1.82e-05	0.000363	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.82e-05	0.000362	CbGpPWpGaD
Lidocaine—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—peripheral nervous system neoplasm	1.8e-05	0.000359	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—ABCB1—peripheral nervous system neoplasm	1.8e-05	0.000359	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.8e-05	0.000358	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.79e-05	0.000356	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.77e-05	0.000352	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ENO2—peripheral nervous system neoplasm	1.73e-05	0.000344	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.7e-05	0.000338	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HGF—peripheral nervous system neoplasm	1.63e-05	0.000324	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.63e-05	0.000324	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—ERBB2—peripheral nervous system neoplasm	1.61e-05	0.00032	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GNS—peripheral nervous system neoplasm	1.6e-05	0.000318	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—BCHE—peripheral nervous system neoplasm	1.59e-05	0.000317	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.59e-05	0.000315	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—HRAS—peripheral nervous system neoplasm	1.57e-05	0.000313	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.57e-05	0.000312	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.56e-05	0.00031	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.55e-05	0.000308	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—ERBB2—peripheral nervous system neoplasm	1.55e-05	0.000308	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—NME1—peripheral nervous system neoplasm	1.53e-05	0.000305	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.52e-05	0.000302	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.52e-05	0.000302	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—TH—peripheral nervous system neoplasm	1.5e-05	0.000298	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	1.48e-05	0.000294	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—COX2—peripheral nervous system neoplasm	1.48e-05	0.000294	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.46e-05	0.000291	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—BCHE—peripheral nervous system neoplasm	1.46e-05	0.00029	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.45e-05	0.000288	CbGpPWpGaD
Lidocaine—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.42e-05	0.000283	CbGpPWpGaD
Lidocaine—EGFR—Axon guidance—HRAS—peripheral nervous system neoplasm	1.42e-05	0.000283	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.4e-05	0.000278	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ENO2—peripheral nervous system neoplasm	1.39e-05	0.000277	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.39e-05	0.000277	CbGpPWpGaD
Lidocaine—EGFR—Signaling by NGF—AKT1—peripheral nervous system neoplasm	1.39e-05	0.000276	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—NRAS—peripheral nervous system neoplasm	1.39e-05	0.000276	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—TH—peripheral nervous system neoplasm	1.37e-05	0.000273	CbGpPWpGaD
Lidocaine—SCN5A—Developmental Biology—AKT1—peripheral nervous system neoplasm	1.37e-05	0.000272	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.36e-05	0.000271	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.35e-05	0.000269	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.3e-05	0.000258	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.3e-05	0.000258	CbGpPWpGaD
Lidocaine—CYP2D6—cerebellum—peripheral nervous system neoplasm	1.27e-05	0.00705	CbGeAlD
Lidocaine—EGFR—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.26e-05	0.000251	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.25e-05	0.000249	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—NRAS—peripheral nervous system neoplasm	1.23e-05	0.000244	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—GNAS—peripheral nervous system neoplasm	1.22e-05	0.000243	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.2e-05	0.000239	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.2e-05	0.000239	CbGpPWpGaD
Lidocaine—EGFR—Immune System—PTPN11—peripheral nervous system neoplasm	1.19e-05	0.000236	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	1.18e-05	0.000235	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—BCHE—peripheral nervous system neoplasm	1.18e-05	0.000234	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—NRAS—peripheral nervous system neoplasm	1.18e-05	0.000234	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	1.15e-05	0.000229	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	1.15e-05	0.000228	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.12e-05	0.000223	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000223	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—TH—peripheral nervous system neoplasm	1.11e-05	0.00022	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.1e-05	0.00022	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.000219	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.1e-05	0.000218	CbGpPWpGaD
Lidocaine—EGFR—Disease—PTPN11—peripheral nervous system neoplasm	1.1e-05	0.000218	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	1.08e-05	0.000215	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	1.05e-05	0.000208	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	1.03e-05	0.000205	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—HRAS—peripheral nervous system neoplasm	1.02e-05	0.000202	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	1e-05	0.000199	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	9.97e-06	0.000198	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ENO2—peripheral nervous system neoplasm	9.69e-06	0.000193	CbGpPWpGaD
Lidocaine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	9.68e-06	0.000192	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	9.65e-06	0.000192	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	9.6e-06	0.000191	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.51e-06	0.000189	CbGpPWpGaD
Lidocaine—EGFR—Immune System—ERBB2—peripheral nervous system neoplasm	9.38e-06	0.000187	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	9.37e-06	0.000186	CbGpPWpGaD
Lidocaine—ABCB1—cerebellum—peripheral nervous system neoplasm	9.14e-06	0.00507	CbGeAlD
Lidocaine—CYP2B6—Metabolism—GNAS—peripheral nervous system neoplasm	9.04e-06	0.00018	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—HRAS—peripheral nervous system neoplasm	8.97e-06	0.000178	CbGpPWpGaD
Lidocaine—EGFR—Developmental Biology—AKT1—peripheral nervous system neoplasm	8.96e-06	0.000178	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—ABCB1—peripheral nervous system neoplasm	8.87e-06	0.000176	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	8.83e-06	0.000176	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	8.69e-06	0.000173	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	8.67e-06	0.000172	CbGpPWpGaD
Lidocaine—EGFR—Disease—ERBB2—peripheral nervous system neoplasm	8.66e-06	0.000172	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—HRAS—peripheral nervous system neoplasm	8.61e-06	0.000171	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.29e-06	0.000165	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	8.21e-06	0.000163	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—BCHE—peripheral nervous system neoplasm	8.18e-06	0.000163	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	8.17e-06	0.000162	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	8.11e-06	0.000161	CbGpPWpGaD
Lidocaine—EGFR—Innate Immune System—AKT1—peripheral nervous system neoplasm	7.92e-06	0.000157	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	7.81e-06	0.000155	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.81e-06	0.000155	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.74e-06	0.000154	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—TH—peripheral nervous system neoplasm	7.7e-06	0.000153	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	7.68e-06	0.000153	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	7.65e-06	0.000152	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	7.63e-06	0.000152	CbGpPWpGaD
Lidocaine—EGFR—Adaptive Immune System—AKT1—peripheral nervous system neoplasm	7.6e-06	0.000151	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	7.51e-06	0.000149	CbGpPWpGaD
Lidocaine—EGFR—Immune System—NRAS—peripheral nervous system neoplasm	7.14e-06	0.000142	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	6.93e-06	0.000138	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	6.67e-06	0.000133	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.61e-06	0.000132	CbGpPWpGaD
Lidocaine—EGFR—Disease—NRAS—peripheral nervous system neoplasm	6.59e-06	0.000131	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	6.52e-06	0.00013	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	6.33e-06	0.000126	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—GNAS—peripheral nervous system neoplasm	6.28e-06	0.000125	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	6.23e-06	0.000124	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—ABCB1—peripheral nervous system neoplasm	6.16e-06	0.000123	CbGpPWpGaD
Lidocaine—EGFR—Disease—MYC—peripheral nervous system neoplasm	6.14e-06	0.000122	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	6.11e-06	0.000122	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	6.07e-06	0.000121	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	5.72e-06	0.000114	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—CASP3—peripheral nervous system neoplasm	5.51e-06	0.00011	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	5.35e-06	0.000106	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	5.32e-06	0.000106	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	5.22e-06	0.000104	CbGpPWpGaD
Lidocaine—EGFR—Immune System—HRAS—peripheral nervous system neoplasm	5.22e-06	0.000104	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.11e-06	0.000102	CbGpPWpGaD
Lidocaine—EGFR—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	5.05e-06	0.0001	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	5.03e-06	0.0001	CbGpPWpGaD
Lidocaine—CYP2C18—Metabolism—AKT1—peripheral nervous system neoplasm	4.96e-06	9.87e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—HRAS—peripheral nervous system neoplasm	4.82e-06	9.59e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—NRAS—peripheral nervous system neoplasm	4.61e-06	9.18e-05	CbGpPWpGaD
Lidocaine—EGFR—Immune System—AKT1—peripheral nervous system neoplasm	4.61e-06	9.17e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—MYC—peripheral nervous system neoplasm	4.3e-06	8.55e-05	CbGpPWpGaD
Lidocaine—EGFR—Disease—AKT1—peripheral nervous system neoplasm	4.26e-06	8.47e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	4.11e-06	8.17e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	4.03e-06	8.02e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—TP53—peripheral nervous system neoplasm	3.53e-06	7.02e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—HRAS—peripheral nervous system neoplasm	3.38e-06	6.72e-05	CbGpPWpGaD
Lidocaine—CYP3A7—Metabolism—AKT1—peripheral nervous system neoplasm	3.3e-06	6.56e-05	CbGpPWpGaD
Lidocaine—CYP2A6—Metabolism—AKT1—peripheral nervous system neoplasm	3.02e-06	6.02e-05	CbGpPWpGaD
Lidocaine—EGFR—Signaling Pathways—AKT1—peripheral nervous system neoplasm	2.98e-06	5.93e-05	CbGpPWpGaD
Lidocaine—CYP2B6—Metabolism—AKT1—peripheral nervous system neoplasm	2.44e-06	4.85e-05	CbGpPWpGaD
Lidocaine—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	2.38e-06	4.74e-05	CbGpPWpGaD
Lidocaine—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	2.07e-06	4.11e-05	CbGpPWpGaD
Lidocaine—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.8e-06	3.58e-05	CbGpPWpGaD
Lidocaine—CYP2D6—Metabolism—AKT1—peripheral nervous system neoplasm	1.7e-06	3.37e-05	CbGpPWpGaD
Lidocaine—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.68e-06	3.34e-05	CbGpPWpGaD
Lidocaine—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.44e-06	2.86e-05	CbGpPWpGaD
Lidocaine—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	1.11e-06	2.21e-05	CbGpPWpGaD
